Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract??? Glucokinase (GK) is a monomeric allosteric enzyme and plays a pivotal role in blood glucose homeostasis. GK is regulated by GK regulatory protein (GKRP), and indirectly by allosteric effectors of GKRP. Despite the critical roles of GK and GKRP, the molecular basis for the allosteric regulation mechanism of GK by GKRP remains unclear. We determined the crystal structure of Xenopus GK and GKRP complex in the presence of fructose-6-phosphate at 2.9 Å. GKRP binds to a super-open conformation of GK mainly through hydrophobic interaction, inhibiting the GK activity by locking a small domain of GK. We demonstrate the molecular mechanism for the modulation of GK activity by allosteric effectors of GKRP. Importantly, GKRP releases GK in a sigmoidal manner in response to glucose concentration by restricting a structural rearrangement of the GK small domain via a single ion pair. We find that GKRP acts as an allosteric switch for GK in blood glucose control by the liver.
Agius,
The physiological role of glucokinase binding and translocation in hepatocytes.
1998, Pubmed
Agius,
The physiological role of glucokinase binding and translocation in hepatocytes.
1998,
Pubmed Agius,
Glucokinase and molecular aspects of liver glycogen metabolism.
2008,
Pubmed Anderka,
Biophysical characterization of the interaction between hepatic glucokinase and its regulatory protein: impact of physiological and pharmacological effectors.
2008,
Pubmed Bebernitz,
Investigation of functionally liver selective glucokinase activators for the treatment of type 2 diabetes.
2009,
Pubmed Bjørkhaug,
Allosteric activation of human glucokinase by free polyubiquitin chains and its ubiquitin-dependent cotranslational proteasomal degradation.
2007,
Pubmed Boyd,
In vitro reversal of the fasting state of liver metabolism in the rat. Reevaluation of the roles of insulin and glucose.
1981,
Pubmed Brown,
Glucokinase regulatory protein may interact with glucokinase in the hepatocyte nucleus.
1997,
Pubmed de la Iglesia,
Glucokinase regulatory protein is essential for the proper subcellular localisation of liver glucokinase.
1999,
Pubmed
,
Xenbase Detheux,
Effectors of the regulatory protein acting on liver glucokinase: a kinetic investigation.
1991,
Pubmed Farrelly,
Mice mutant for glucokinase regulatory protein exhibit decreased liver glucokinase: a sequestration mechanism in metabolic regulation.
1999,
Pubmed Futamura,
An allosteric activator of glucokinase impairs the interaction of glucokinase and glucokinase regulatory protein and regulates glucose metabolism.
2006,
Pubmed Goodey,
Allosteric regulation and catalysis emerge via a common route.
2008,
Pubmed Grimsby,
Allosteric activators of glucokinase: potential role in diabetes therapy.
2003,
Pubmed Hallfrisch,
Effects of dietary fructose on plasma glucose and hormone responses in normal and hyperinsulinemic men.
1983,
Pubmed Hawkins,
Fructose improves the ability of hyperglycemia per se to regulate glucose production in type 2 diabetes.
2002,
Pubmed Iynedjian,
Tissue-specific expression of glucokinase: identification of the gene product in liver and pancreatic islets.
1986,
Pubmed Kamata,
Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase.
2004,
Pubmed Matschinsky,
Assessing the potential of glucokinase activators in diabetes therapy.
2009,
Pubmed Matschinsky,
Research and development of glucokinase activators for diabetes therapy: theoretical and practical aspects.
2011,
Pubmed Matschinsky,
Glucokinase as pancreatic beta cell glucose sensor and diabetes gene.
1993,
Pubmed Nordlie,
Regulation of glucose production by the liver.
1999,
Pubmed Olson,
Structure, function, and regulation of the mammalian facilitative glucose transporter gene family.
1996,
Pubmed Pfefferkorn,
Discovery of (S)-6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid as a hepatoselective glucokinase activator clinical candidate for treating type 2 diabetes mellitus.
2012,
Pubmed Shiota,
Inclusion of low amounts of fructose with an intraduodenal glucose load markedly reduces postprandial hyperglycemia and hyperinsulinemia in the conscious dog.
2002,
Pubmed Shiota,
Nuclear import of hepatic glucokinase depends upon glucokinase regulatory protein, whereas export is due to a nuclear export signal sequence in glucokinase.
1999,
Pubmed Teplyakov,
Involvement of the C terminus in intramolecular nitrogen channeling in glucosamine 6-phosphate synthase: evidence from a 1.6 A crystal structure of the isomerase domain.
1998,
Pubmed Toyoda,
Evidence for glucokinase translocation by glucose in rat hepatocytes.
1994,
Pubmed Vandercammen,
Competitive inhibition of liver glucokinase by its regulatory protein.
1991,
Pubmed Vandercammen,
Species and tissue distribution of the regulatory protein of glucokinase.
1993,
Pubmed
,
Xenbase Van Schaftingen,
A protein from rat liver confers to glucokinase the property of being antagonistically regulated by fructose 6-phosphate and fructose 1-phosphate.
1989,
Pubmed Veiga-da-Cunha,
Identification of fructose 6-phosphate- and fructose 1-phosphate-binding residues in the regulatory protein of glucokinase.
2002,
Pubmed
,
Xenbase Veiga-da-Cunha,
Amino acid conservation in animal glucokinases. Identification of residues implicated in the interaction with the regulatory protein.
1996,
Pubmed
,
Xenbase Veiga-da-Cunha,
Evolution of vertebrate glucokinase regulatory protein from a bacterial N-acetylmuramate 6-phosphate etherase.
2009,
Pubmed
,
Xenbase Veiga-Da-Cunha,
Cloning and expression of a Xenopus liver cDNA encoding a fructose-phosphate-insensitive regulatory protein of glucokinase.
1994,
Pubmed
,
Xenbase Vionnet,
Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus.
1992,
Pubmed Zorn,
Turning enzymes ON with small molecules.
2010,
Pubmed
